Literature DB >> 14707141

hGTSE-1 expression stimulates cytoplasmic localization of p53.

Martin Monte1, Roberta Benetti, Licio Collavin, Luigi Marchionni, Giannino Del Sal, Claudio Schneider.   

Abstract

hGTSE-1 (human G(2) and S phase-expressed-1) is a cell cycle-regulated protein mainly localized in the cytoplasm and apparently associated with the microtubules. hGTSE-1 is able to down-regulate levels and activity of the p53 tumor suppressor protein: it binds the C-terminal region of p53 and represses its ability to induce apoptosis after DNA damage. Here we report that, after DNA damage, hGTSE-1 becomes stabilized in a p53-independent way and accumulated in the nucleus. Further characterization of hGTSE-1 localization revealed increased nuclear staining in unstressed cells after treatment with the nuclear export inhibitor leptomycin B, or when a nuclear export signal (NES) located in its C-terminal region was mutated. Finally, we provide evidence that hGTSE-1 ectopic expression, in addition to p53 protein levels down-regulation, is able to enhance cytoplasmic localization of p53. Interestingly, NES-mutated hGTSE-1 accumulates in the nucleus, binds p53 but looses its ability to enhance cytoplasmic redistribution of p53 and to regulate p53 protein levels. Similarly, when wild type hGTSE-1 functions on p53 were analyzed in cells lacking Mdm2, it failed in regulating both p53 localization and protein levels, thus indicating that hGTSE-1 requires an intact NES and functional Mdm2 for the regulation of p53. Our results provide new insights into the mechanism of hGTSE-1 function, whereby its characterized nucleo-cytoplasmic shuttling ability is required to regulate p53.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14707141     DOI: 10.1074/jbc.M311123200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma.

Authors:  Xiaofeng Zhou; Stephane Temam; Myungshin Oh; Nisa Pungpravat; Bau-Lin Huang; Li Mao; David T Wong
Journal:  Neoplasia       Date:  2006-11       Impact factor: 5.715

2.  Polo-like kinase 1 phosphorylation of G2 and S-phase-expressed 1 protein is essential for p53 inactivation during G2 checkpoint recovery.

Authors:  X Shawn Liu; Hongchang Li; Bing Song; Xiaoqi Liu
Journal:  EMBO Rep       Date:  2010-06-25       Impact factor: 8.807

3.  Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapy.

Authors:  Jedd M Hillegass; Steven R Blumen; Kai Cheng; Maximilian B MacPherson; Vlada Alexeeva; Sherrill A Lathrop; Stacie L Beuschel; Jeremy L Steinbacher; Kelly J Butnor; Maria E Ramos-Niño; Arti Shukla; Ted A James; Daniel J Weiss; Douglas J Taatjes; Harvey I Pass; Michele Carbone; Christopher C Landry; Brooke T Mossman
Journal:  Int J Cancer       Date:  2010-11-03       Impact factor: 7.396

Review 4.  The substrates of Plk1, beyond the functions in mitosis.

Authors:  X Shawn Liu; Bing Song; Xiaoqi Liu
Journal:  Protein Cell       Date:  2010-12-10       Impact factor: 14.870

5.  Human GTSE-1 regulates p21(CIP1/WAF1) stability conferring resistance to paclitaxel treatment.

Authors:  Débora Rosa Bublik; Massimiliano Scolz; Gianluca Triolo; Martín Monte; Claudio Schneider
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

6.  Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis.

Authors:  Paola Dongiovanni; Anna Ludovica Fracanzani; Gaetano Cairo; Chiara Paola Megazzini; Stefano Gatti; Raffaela Rametta; Silvia Fargion; Luca Valenti
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

7.  Quantitative proteomics combined with BAC TransgeneOmics reveals in vivo protein interactions.

Authors:  Nina C Hubner; Alexander W Bird; Jürgen Cox; Bianca Splettstoesser; Peter Bandilla; Ina Poser; Anthony Hyman; Matthias Mann
Journal:  J Cell Biol       Date:  2010-05-17       Impact factor: 10.539

8.  A human functional protein interaction network and its application to cancer data analysis.

Authors:  Guanming Wu; Xin Feng; Lincoln Stein
Journal:  Genome Biol       Date:  2010-05-19       Impact factor: 13.583

Review 9.  Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics.

Authors:  Rosie Elizabeth Ann Gutteridge; Mary Ann Ndiaye; Xiaoqi Liu; Nihal Ahmad
Journal:  Mol Cancer Ther       Date:  2016-06-21       Impact factor: 6.261

10.  Development of a high-throughput method for the systematic identification of human proteins nuclear translocation potential.

Authors:  Trinh Xuan Hoat; Nicolas Bertin; Noriko Ninomiya; Shiro Fukuda; Kengo Usui; Jun Kawai; Yoshihide Hayashizaki; Harukazu Suzuki
Journal:  BMC Cell Biol       Date:  2009-09-22       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.